Catheter ablation to treat supraventricular tachycardia is not detrimental to patients A recent study published in Pacing and Clinical Electrophysiology determined that the use of catheter ablation to treat supraventricular tachycardia isn’t detrimental to individuals low risk . This data refutes prior proof which suggested a high incidence of problems for a patient’s cardiac nerves, possibly resulting in accelerated heart rates following a procedure. Related StoriesCertain antibiotic treatment for MRSA may possibly make sufferers sickerMycobacterium could be more effective in dealing with superficial bladder cancer, research findsUAB performs life-conserving TAVR process on Selma residentThis study, supported in part by the National Institute of Health and led by Steven M.
This program commenced enrollment in the initial quarter of 2014. Rick Anderson, President and COO commented, ‘We signed two national programs in 2013, getting us to five operational healthcare services contracts. They are pivotal events as we anticipate that both combined national programs, along with other new plans will provide the vital mass that we need to be cashflow positive as those programs ramp up to full enrollment. We have proven our business model and are attaining significant momentum. Expanding enrollment %ages are offering a powerful revenue driver to our business design.’ Mr. Anderson continued, ‘In the first one fourth of 2014 we signed our first Medicaid plan, which has already launched in one state.